Haeli Bio: Subsidiary’s artificial bone products obtain registration certificates in Vietnam

MetaMuskRat · 2026-03-28T16:20:24+00:00

People's Financial News, March 27 — Haili Bio (603718) announced on March 27 that its controlling subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (referred to as "Ruisheng Bio"), submitted registration materials for artificial bone products to the Vietnamese Ministry of Health in September 2025. Ruisheng Bio recently received notification from the Vietnamese Ministry of Health that its artificial bone product has been approved. The product is used for jawbone defect repair and is utilized in oral surgeries to reconstruct alveolar bone tissue in patients with missing teeth, addressing the issue of insufficient bone volume in the implant sites of patients with missing teeth.

MetaMuskRat

2026-03-28 16:20:24

People’s Financial News, March 27 - Haili Biology (603718) announced on March 27 that its holding subsidiary, Shaanxi Ruisheng Biotechnology Co., Ltd. (referred to as “Ruisheng Biology”), submitted registration application materials for artificial bone products to the Vietnam Ministry of Health in September 2025. Ruisheng Biology recently received notification from the Vietnam Ministry of Health that its artificial bone products have been approved. This product is used for the repair of mandibular defects and is used in oral surgery to reconstruct the alveolar bone tissue in the implant area of patients with missing teeth, addressing the issue of insufficient bone volume in the implant area for patients with missing teeth.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.